Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
BTX306
i
Other names:
BTX306
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
BioTheryX
Drug class:
Protein homeostatic modulator
‹
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
SDC1 positive
Multiple Myeloma
SDC1 positive
Multiple Myeloma
bortezomib + BTX306
Sensitive: D – Preclinical
bortezomib + BTX306
Sensitive
:
D
bortezomib + BTX306
Sensitive: D – Preclinical
bortezomib + BTX306
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login